GlassScriptPhysician profile
Larry Keith Routh
NPI 1053375550
$21,829.24
in general payments reported to CMS, 2019-2025
34 companies · $1,763 in 2025
The $1,763 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,602 · 2020: $1,041 · 2021: $1,996 · 2022: $2,351 · 2023: $2,042 · 2024: $7,034 · 2025: $1,763.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,493 · Long Term Medical Supply Or Device Loan: $5,125 · Travel and Lodging: $222.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,492.76 |
| Long Term Medical Supply Or Device Loan | $5,125.00 |
| Travel and Lodging | $221.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $6,822.82 | 2019-2025 | Aveir, Jot Dx, Xience Skypoint |
| Angiodynamics, INC. | $5,125.00 | 2023-2024 | Auryon Laser System 100-120 Vac |
| Medtronic, INC. | $1,896.38 | 2021-2025 | Onyx Frontier, Symplicity G3, Resolute Onyx |
| Edwards Lifesciences Corporation | $1,365.06 | 2019-2025 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Boston Scientific Corporation | $847.83 | 2019-2024 | Mamba, Opticross, Avvigo Guidance System |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $776.91 | 2019-2023 | Lifevest |
| Impulse Dynamics (USA) INC. | $701.60 | 2022-2023 | Optimizer |
| Shockwave Medical, INC | $609.27 | 2021-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Medtronic Vascular, INC. | $465.82 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $441.36 | 2019-2025 | |
| Pfizer INC. | $430.51 | 2019-2022 | |
| Amarin Pharma, INC. | $367.79 | 2019-2021 | |
| Biotronik INC. | $286.89 | 2019-2022 | |
| Heartflow, INC. | $269.99 | 2022-2025 | |
| Abiomed | $269.65 | 2019-2022 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $210.21 | 2019-2025 | Camzyos, Eliquis |
| Amgen INC. | $152.98 | 2021-2025 | Repatha, Repatha |
| Janssen Pharmaceuticals, INC | $146.79 | 2019-2024 | Xarelto |
| Boehringer Ingelheim Pharmaceuticals, INC. | $122.58 | 2019-2025 | Jardiance |
| Novo Nordisk INC | $72.37 | 2022-2025 | Wegovy, Ozempic |
| Merck Sharp & Dohme LLC | $60.97 | 2025 | Verquvo |
| Sanofi-Aventis U.S. LLC | $60.71 | 2019-2021 | |
| Lexicon Pharmaceuticals, INC. | $52.41 | 2024 | |
| Astrazeneca Pharmaceuticals LP | $51.54 | 2019-2022 | |
| Philips North America LLC | $37.44 | 2021 | |
| Kiniksa Pharmaceuticals International, Plc | $30.50 | 2024 | Arcalyst |
| Chiesi USA, INC. | $24.90 | 2021 | |
| Arbor Pharmaceuticals, INC. | $24.80 | 2020-2022 | |
| Cardiva Medical, INC. | $24.65 | 2024 | Optowire |
| Astellas Pharma US INC | $22.76 | 2021 | |
| Cook Medical LLC | $18.15 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $13.99 | 2019 | |
| Esperion Therapeutics, INC. | $13.88 | 2021 | |
| Elutia, INC. | $10.73 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Larry Routh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.